Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
21 pending office actions • 13 art units • 21 examiners • 0 of 21 (0%) have an AI response strategy ready • 28 patents granted in the last 365 days
The University of Georgia Research Foundation Inc. currently manages 22 pending office actions. These filings are categorized within the Biotechnology & Pharmaceuticals technology area. The portfolio is characterized by a high degree of examiner diversity, with 22 distinct examiners assigned to the 22 pending actions. This one-to-one ratio between actions and examiners means that no single examiner has more than 1 pending case, as seen with the busiest examiner, ROBINSON, KEITH O NEAL, who holds 1 pending action.
The 22 pending actions are spread across 14 distinct art units. This wide distribution across 14 units indicates that the foundation's biotechnological research covers a broad array of specialized sub-disciplines within the USPTO. For a practitioner, managing this portfolio requires coordinating with 22 different individuals across 14 different administrative units. There is no central examiner bottleneck, but the lack of examiner overlap prevents the application of specific examiner-derived insights across multiple cases. Each of the 22 actions must be prosecuted as a unique interaction, as the data shows no concentration of cases under any single official.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (24%) |
| §103 only | 5 (24%) |
| §112 only | 1 (5%) |
| Double-patenting + other | 2 (10%) |
| Multi-statute (no §101) | 8 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROBINSON, KEITH O NEAL | 1 | 91.6% | +3.8% |
| HAUK TEODORO, PRICILA NMN | 1 | 50.0% | +0.0% |
| SONG, JIANFENG | 1 | 56.3% | +33.2% |
| ESPINOSA, CLAUDIA EDILMA | 1 | 50.9% | +57.7% |
| BLUMEL, BENJAMIN P | 1 | 70.8% | +30.5% |
| DEVI, SARVAMANGALA | 1 | 65.3% | +55.3% |
| PIPIC, ALMA | 1 | 54.6% | +54.7% |
| PHILLIPS, SAVANNAH GRACE | 1 | — | — |
| PROSSER, ALISSA J | 1 | 15.7% | +11.2% |
| LAU, EDMOND C | 1 | 71.7% | +8.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18282705 | ULTRASMALL GADOLINIUM-INTERCALATED CARBON DOTS AS A RADIOSENSITIZING AGENT FOR CANCER | ROGERS, JAMES WILLIAM | 39d |
| 19192111 | ENGINEERING TOMATO FRUITS AS A PRODUCTION PLATFORM FOR TERPENOID PRODUCTS | ROBINSON, KEITH O NEAL | — |
| 19085932 | IMMUNOGENIC ANTI-FUNGAL POLYPEPTIDES, COMPOSITIONS AND METHODS THEREOF | HAUK TEODORO, PRICILA NMN | — |
| 18849109 | A NOVEL H1N1 ANTIBODY | BLUMEL, BENJAMIN P | — |
| 18846326 | LIVE MYCOPLASMA SYNOVIAE VACCINE | DEVI, SARVAMANGALA | — |
| 18833322 | RADIOSENSITIZING COMPOSITIONS AND METHODS OF USE THEREOF | PIPIC, ALMA | — |
| 18682184 | ANTIBACTERIAL PORPHYRIN NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME | PROSSER, ALISSA J | — |
| 18428342 | Light Sheet Microscopy | LAU, EDMOND C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18935724 | DIETARY EARLY GLYCATION PRODUCTS FOR TREATING AND PREVENTING AUTOIMMUNE DISEASES | ESPINOSA, CLAUDIA EDILMA | 13d |
| 18990391 | NANOPARTICLES FOR PREVENTING PERI/POST-MENOPAUSAL BONE LOSS AND/OR OBESITY | SONG, JIANFENG | — |
| 18849109 | A NOVEL H1N1 ANTIBODY | BLUMEL, BENJAMIN P | — |
| 18846326 | LIVE MYCOPLASMA SYNOVIAE VACCINE | DEVI, SARVAMANGALA | — |
| 18833322 | RADIOSENSITIZING COMPOSITIONS AND METHODS OF USE THEREOF | PIPIC, ALMA | — |
| 18682184 | ANTIBACTERIAL PORPHYRIN NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME | PROSSER, ALISSA J | — |
| Art Unit | Apps |
|---|---|
| 1618 | 2 |
| 1798 | 2 |
| 1661 | 1 |
| 1654 | 1 |
| 1617 | 1 |
| 1619 | 1 |
| 2871 | 1 |
| 1625 | 1 |
| 1672 | 1 |
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19192111 | ENGINEERING TOMATO FRUITS AS A PRODUCTION PLATFORM FOR TERPENOID PRODUCTS | ROBINSON, KEITH O NEAL | 1661 | §101§103§112Other | Non-Final OA | — | Pending | Apr 28, 2025 |
| 19085932 | IMMUNOGENIC ANTI-FUNGAL POLYPEPTIDES, COMPOSITIONS AND METHODS THEREOF | HAUK TEODORO, PRICILA NMN | — | §103§112 | Non-Final OA | — | Pending | Mar 20, 2025 |
| 18990391 | NANOPARTICLES FOR PREVENTING PERI/POST-MENOPAUSAL BONE LOSS AND/OR OBESITY | SONG, JIANFENG | — | §103§112DP | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18935724 | DIETARY EARLY GLYCATION PRODUCTS FOR TREATING AND PREVENTING AUTOIMMUNE DISEASES | ESPINOSA, CLAUDIA EDILMA | 1654 | §112 | Final Rejection | 13d | Pending | Nov 04, 2024 |
| 18849109 | A NOVEL H1N1 ANTIBODY | BLUMEL, BENJAMIN P | — | §102§112Other | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18846326 | LIVE MYCOPLASMA SYNOVIAE VACCINE | DEVI, SARVAMANGALA | — | §101§102§112 | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18833322 | RADIOSENSITIZING COMPOSITIONS AND METHODS OF USE THEREOF | PIPIC, ALMA | 1617 | §103§112 | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18693198 | NITRIC OXIDE RELEASING POLYSILOXANES AND METHODS FOR MAKING AND USING THE SAME | PHILLIPS, SAVANNAH GRACE | — | §103DP | Final Rejection | — | Pending | Mar 19, 2024 |
| 18682184 | ANTIBACTERIAL PORPHYRIN NANOPARTICLES AND METHODS FOR MAKING AND USING THE SAME | PROSSER, ALISSA J | 1619 | §103 | Final Rejection | — | Pending | Feb 08, 2024 |
| 18428342 | Light Sheet Microscopy | LAU, EDMOND C | 2871 | §102§103§112 | Non-Final OA | — | Pending | Jan 31, 2024 |
| 18577631 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS | BELL, SARA ELIZABETH | 1625 | §102§103§112 | Non-Final OA | — | Pending | Jan 08, 2024 |
| 18528067 | BROADLY REACTIVE VIRAL ANTIGENS AS IMMUNOGENS, COMPOSITIONS AND METHODS OF USE THEREOF | CHEN, STACY BROWN | 1672 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18561613 | NITRIC OXIDE-RELEASING DISINFECTION INSERT | SPAMER, DONALD R | 1799 | §103 | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18282705 | ULTRASMALL GADOLINIUM-INTERCALATED CARBON DOTS AS A RADIOSENSITIZING AGENT FOR CANCER | ROGERS, JAMES WILLIAM | 1618 | §102§103 | Non-Final OA | 39d | Pending | Sep 18, 2023 |
| 18242921 | METHODS AND SYSTEMS FOR PHOSPHORMER MODEL EVALUATION | KRIANGCHAIVECH, KETTIP | — | §101§102§112 | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18105071 | HYDROGEN GAS SENSORS USING MAGNETO-PLASMONIC NANOLATTICES | GZYBOWSKI, MICHAEL STANLEY | 1798 | §103 | Final Rejection | 60d overdue | Pending | Feb 02, 2023 |
| 17596351 | TELMISARTAN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE IN DOGS | CHONG, YONG SOO | 1623 | §103 | Non-Final OA | — | Pending | Dec 08, 2021 |
| 17514795 | DYNAMIC POLYMER SURFACES FOR SCREENING, ENRICHMENT, AND HARVESTING OF CELLS AND OTHER SOFT COLLOIDAL PARTICLES | KWAK, DEAN P | 1798 | §102§103§112 | Non-Final OA | — | Pending | Oct 29, 2021 |
| 17434909 | REACTIVE ELECTROCHEMICAL MEMBRANE SYSTEM AND METHODS OF MAKING AND USING | JEBUTU, MOFOLUWASO SIMILOLUWA | 1795 | §102§103 | Non-Final OA | — | Pending | Aug 30, 2021 |
| 17427528 | CONTACTLESS MONITORING OF SLEEP ACTIVITIES AND BODY VITAL SIGNS VIA SEISMIC SENSING | FEDORKY, MEGAN TAYLOR | 3796 | §101§103§112 | Non-Final OA | — | Pending | Jul 30, 2021 |
| 17421069 | TARGETED NANOPARTICLES AND THEIR USES RELATED TO FUNGAL INFECTIONS | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Final Rejection | — | Pending | Jul 07, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial